MeSH D020250 - postoperative nausea and vomiting
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Salix Pharmaceuticals | Metoclopramide | Metozolv |  | 2009-09-04 |  |  |
| Teva | Metoclopramide | Metoclopramide |  | 1985-07-29 |  |  |
| Sandoz | Metoclopramide | Metoclopramide |  | 1987-02-03 |  |  |
| King Pharmaceuticals | Metoclopramide | Maxolon |  | 1986-03-04 |  |  |
| Merck & Co | Aprepitant | Emend |  | 2003-11-11 | $145 M | Y2020 |
| Metoclopramide | Metoclopramide |  | 1987-02-02 |  |  | |
| Sun Pharmaceutical Industries | Metoclopramide | Metoclopramide |  | 1993-04-28 |  |  |
| Hospira | Metoclopramide | Metoclopramide |  | 1989-06-23 |  |  |
| AiPing Pharmaceutical | Metoclopramide | Metoclopramide |  | 1990-01-30 |  |  |
| Chartwell Pharmaceuticals | Metoclopramide | Metoclopramide |  | 1992-10-27 |  |  |
| Impax Laboratories | Metoclopramide | Metoclopramide |  | 1988-02-03 |  |  |
1
2
3
>
Clinical Trials
Historical Success Rate
Phase 1
100%12/12
Phase 2
78%29/37
Phase 3
85%29/34
Approved: 3Overall Success rate: 67%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use